Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)
This study is currently recruiting participants.
Verified January 2010
by University of Louisville
Study NCT00683631 Information provided by University of Louisville
First Received on May 16, 2008. Last Updated on January 12, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatocellular Carcinoma
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Hepatocellular
More general conditions related to this trial
Adenocarcinoma
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial
Interventions listed in this trial
TheraSphere HUD
Sponsors listed in this trial
University of Louisville
MDS Pharma Services
Back to top of Main Content